Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization-Reference-Cited by-同舟云学术

Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization

Published:2008-11 Issue:3 Volume:76 Page:180-188
ISSN:0026-2862
Container-title:Microvascular Research
language:en
Short-container-title:Microvascular Research

Author:

Bagley Rebecca G.,Honma Nakayuki,Weber William,Boutin Paula,Rouleau Cecile,Shankara Srinivas,Kataoka Shiro,Ishida Isao,Roberts Bruce L.,Teicher Beverly A.

Publisher

Elsevier BV

Subject

Cell Biology,Cardiology and Cardiovascular Medicine,Biochemistry

Reference42 articles.

1. Pericytes: cell biology and pathology;Allt;Cells Tissues Organs,2001

2. Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy;Bagley;Cancer Res.,2005

3. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors;Baluk;Am. J. Pathol.,2003

4. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors;Bergers;J. Clin. Invest.,2003

5. Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors;Brady;J. Neuropathol. Exp. Neurol.,2004

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T cell technologies that interact with the tumour microenvironment in solid tumours;Expert Review of Clinical Immunology;2024-07-17

2. Visfatin (NAMPT) affects global gene expression in porcine anterior pituitary cells during the mid-luteal phase of the oestrous cycle;Journal of Animal Science and Biotechnology;2024-07-09

3. Microstructure changes and miRNA-mRNA network in a developmental dysplasia of the hip rat model;iScience;2024-04

4. Placenta accreta spectrum disorder at single-cell resolution: a loss of boundary limits in the decidua and endothelium;American Journal of Obstetrics and Gynecology;2024-04

5. CD93 maintains endothelial barrier function and limits metastatic dissemination;JCI Insight;2024-03-05